Skip to main content

Psoriaris descentralized imaging capture

Close-up perspectives​

Study Information​

Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis​

  • Study Title: A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
  • Investigational Product: JNJ-77242113

Version 0.01 - Version Date: 2025-12-16